The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

Alimentary Pharmacology and Therapeutics

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/23Jr7To
via IFTTT